Scientist, Non-Viral Gene Editing Platforms

The Scientist, Non-Viral Gene Editing Platforms role at Bristol Myers Squibb focuses on developing next-generation, engineered cell-based therapies to treat hematologic malignancies, solid cancers, and autoimmune diseases. The position involves independently executing experiments, optimizing base ex vivo editing platforms, and characterizing engineered CAR-T cells through various analytical methods. This role requires collaboration within a multidisciplinary team to drive continuous improvement and support the development of transformative immune-based therapies.